The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The Department of the Army Medical Command awarded Brigham & Women's Hospital Inc. a $749,999 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to investigate lymphocyte dynamics and identify early biomarkers for systemic lupus erythematosus (SLE). The three-year award, beginning September 30, 2022, will support research to dissect lymphocyte dynamics and behavior through single-cell profiling and other advanced techniques to uncover pathways and...
The U.S. Department of the Army Medical Command has awarded a $577,383.00 Project Grant to The Children's Hospital Corporation, doing business as Boston Children's Hospital, under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant, with a performance period from September 1, 2024 to August 31, 2027, will support the hospital's research to develop base editing techniques to improve conditioning and transplantation of bone marrow failure patients. As a...
The Department of the Army Medical Command awarded a $1,416,000 project grant to Boston Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to define leukemia stem cells in acute lymphoblastic leukemia from September 2021 through September 2025. Through this funding, Boston Children's Hospital researchers will investigate medical solutions for the battlefield by transforming healthcare for service members and the public. The...
This Project Grant award, valued at $3,062,579.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The award will support an integrated research approach to identify biopsychosocial aspects of pain in individuals with fibrous dysplasia/McCune-Albright syndrome over a period of 4 years, from April 2025 to April 2029. As a premier pediatric...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $777,927 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support research into targeting PARP signaling as a novel treatment for urologic complications of spinal cord injury from August 15, 2023 through August 14, 2026. The Military Medical Research and Development program aims to advance biomedical solutions for battlefield...
This $1,000,000 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) program will support advanced biomedical research by the Childrens Hospital Medical Center in Cincinnati, Ohio. The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund research focused on "Follicular T-Cell Targeting in Therapy of Lupus". As a leading pediatric hospital and research institution, Childrens...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $796,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2021 through June 2024 to investigate the contribution of rapamycin-insensitive processes to neurological symptoms in tuberous sclerosis complex. The Military Medical Research and Development program aims to advance biomedical...
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...